Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Peripheral Nervous System Diseases × Acetylcysteine × Clear all

Phase

Phase NA 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Thrombocythemia, Essential 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Peripheral Nervous System Diseases 1 Ovarian Neoplasms 1 Myeloproliferative Disorders 1 Hearing Loss, Sensorineural 1 Hearing Loss 1 Ear Diseases 1 Deafness 1 Cognitive Dysfunction 1 Chemotherapy-Related Cognitive Impairment 1

Interventions

Trimetazidine 1 Thioctic Acid 1 Surveys and Questionnaires 1 Paclitaxel 1 Cilostazol 1 Carnosine 1 Acupuncture Therapy 1 Acetylcysteine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03492047 2020-02-27

N-acetyl Cysteine Effect in Peripheral Neuropathy in Cancer Patients

Ain Shams University

Phase 1/2 Completed

Peripheral Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡